• Nenhum resultado encontrado

Rev. Bras. Hematol. Hemoter. vol.37 número6

N/A
N/A
Protected

Academic year: 2018

Share "Rev. Bras. Hematol. Hemoter. vol.37 número6"

Copied!
2
0
0

Texto

(1)

revbrashematolhemoter.2015;37(6):369–370

w w w . r b h h . o r g

Revista

Brasileira

de

Hematologia

e

Hemoterapia

Brazilian

Journal

of

Hematology

and

Hemotherapy

Scientific

Comment

Scientific

comment

on

health-related

quality

of

life

among

blood

donors

with

hepatitis

B

and

hepatitis

C:

longitudinal

study

before

and

after

diagnosis?

Simone

Cristina

Olenscki

Gilli

CentrodeHematologiaeHemoterapia(HEMOCENTRO),UniversidadeEstadualdeCampinas(UNICAMP),Campinas,SP,Brazil

a

r

t

i

c

l

e

i

n

f

o

Articlehistory:

Received2September2015 Accepted2September2015 Availableonline9October2015

Theblood donationprocessismuchmorecomplexthan is generallyimaginedand doesnotendwiththedepartureof thedonorfromthedonationcenter;theprocesstranscends farbeyondthat.Withoutbeingawareofthefact,thedonor maydepartwithamemorythattheexperiencewasorwas notsatisfactory whichmay last forseveralyears afterand we cannot forget that a positive donation experience has beenrecognized asthemajordeterminantofdonorreturn behavior.Accordingly,donorsshouldbemanaged inaway thatensureshighstandardsofcareandassuresthemofthe concernofthe blood transfusion staff fortheir healthand well-being.

Thedonationexperienceshouldalwaysbepleasurablefor severalreasons: notonlyistheact oneofaltruism,which alwaysbringsasenseofsatisfaction,butbydonatingthe indi-vidualbecomesanactivememberofthecommunityinwhich heor sheisinserted,enablingthemtoparticipate,atleast indirectly,inpromotingthehealthofthecommunity.

DOIoforiginalarticle:http://dx.doi.org/10.1016/j.bjhh.2015.08.004.

SeepaperbyFerreiraetal.onpages381–7.

Correspondingauthorat:UniversidadeEstadualdeCampinas(UNICAMP),FaculdadedeCiênciasMédicas,RuaCarlosChagas,480,Barão Geraldo,13083-970Campinas,SP,Brazil.

E-mailaddress:[email protected]

Nevertheless,whatisexpectedisoftendifferenttowhat happens;let usthinkwhy. Thewordatthis pointis infor-mation.Informationinblooddonationcomprisesanumber ofstages.Beforethedonation,thedonorisinformed about theprocedureshe/shewillundergo,followedbythe counsel-ingphaseduringwhichtheinterviewemphasizesthemedical history,healthandriskofinfectionsthatcouldbetransmitted throughtransfusion,endingwithcounselingaftertheblood donationandtestingofdonatedbloodforbloodgroupserology andinfectionmarkers.1Theaimsofthesestagesare numer-ousbutincludeimprovingdonorawarenessandtrustinthe blood transfusion service, encouragement toadhereto the donorselectioncriteria,duringwhichtheindividual’s suitabil-itytodonatebloodiscarefullyassessedandthecounseling ofdonorswhohaveuncommonredcellserology,rareblood groupsorabnormaltransfusion-transmissibleinfections.All oftheseareanessentialpartofthequalityofthedonation serviceanddonorcare.

http://dx.doi.org/10.1016/j.bjhh.2015.09.002

(2)

370

revbrashematolhemoter.2015;37(6):369–370

When donors are found to beinfected, they should be notified oftheir infection status, counseled, deferred from blooddonationandreferredfortreatment,careandsupport.2 Counselingafterdonationshouldalwaysbeconductedina safe and conducive environment that protects the donor’s confidentialityusingalanguagefamiliartothedonorandin aculturallysensitivemanner.

Becauseofthestigmaanddiscriminationthatmayarise from having a positive transfusion-transmissible infection testresult,itisvitalthatbloodtransfusionservicestaff under-standthatanysensitiveinformationgivenbydonorsmustbe keptstrictlyconfidentialatalltimes.

Thepsychologicalimpact ofapositive serologicalresult followingblooddonationbydonorswho,untilthatmoment, perceivedthemselvestobehealthyismixedand mayvary from a need for care, support and access to treatment to depression,blameandlossofqualityoflife.Previous iden-tification ofthe possibilitiesand theuse ofinstruments to minimizethenegativeimpactofthisinformationonblood donorswould increasethe health-relatedquality of lifeof blooddonors,andwouldrenderthedonationprocessmore complete,humaneandsatisfactory.

In this issue of the Revista Brasileira de Hematologia e Hemoterapia, Ferreira et al. evaluate the impact of the

notificationoftestresultsforhepatitisBandhepatitisCon thequalityoflifeofblooddonors.3

Conflicts

of

interest

Theauthordeclaresnoconflictsofinterest.

r

e

f

e

r

e

n

c

e

s

1.WHOGuidelinesApprovedbytheGuidelinesReview Committee.Blooddonorcounselling:implementation guidelines.Geneva:WorldHealthOrganization;2014.Available from:http://www.who.int/bloodsafety/voluntarydonation/

Blooddonorcounselling.pdf[cited02.09.15].

2.Brasil.MinistériodaSaúdeRedefineoregulamentotécnicode procedimentoshemoterápicos.[cited2015September02] PortariaN◦2.712,de12denovembrode2013.Availablefrom:

http://www.jusbrasil.com.br/diarios/61650953/dou-secao-1-13-11-2013-pg-106.

3.FerreiraFB,Almeida-NetoC,TeixeiraMC,StraussE.

Health-relatedqualityoflifeamongblooddonorswith

hepatitisBandhepatitisC:longitudinalstudybeforeandafter

Referências

Documentos relacionados

Sequential monitoring of MRD using more sensitive and specific techniques, such as quantitative real-time poly- merase chain reaction (RQ-PCR) for immunoglobulin ( Ig ) and

Clostridium difficile infection after adult autologous stem cell transplantation: a multicenter study of epidemiology and risk factors. Biol Blood

Figure 3 – Leukemia-free survival according to minimal residual disease based on real-time quantitative polymerase chain reaction at the end of induction in 44 children with

The exclusion criteria were (1) donors who were previously aware of their serological status for HBV and HCV; (2) donors with positive serologic screening tests for human

Clostridium difficile infection in allogeneic stem cell transplant recipients is associated with severe graft-versus-host disease and non-relapse mortality. Bone

Therefore, this study does not support data published for patients without neutropenia; the CD64 index was not able to predict positive blood culture results in this specific

Intravenous iron sucrose versus oral iron supplementation for the treatment of iron deficiency anemia in patients with inflammatory bowel disease – a randomized, controlled,

positive precursor B-cell acute lymphoblastic leukemia with positive minimal residual disease (0.32%) before conditioning treatment for hematopoietic stem cell transplantation..